KAN-003 seeks to improve outcomes for patients with ICI-naive cancers and is undergoing preclinical studies in collaboration with the MD Anderson Cancer Center. PRINCETON, N.J., June 20, 2024 /PRNewswire/ — Kanvas Biosciences, a full-stack spatial biology company, today introduced its…